Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002302

EVP, Global Head RA & Quality sold 963 shares at an average $6.63 ($6,384)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Henrich Jill EVP, Global Head RA & Quality 2024-08-16 Sale −831 $6.63 $5,509 20,510 D: show line 1 in the form
Henrich Jill EVP, Global Head RA & Quality 2024-08-16 Sale −132 $6.63 $875 20,378 D: show line 2 in the form
Open-market sales · 963 sh · avg $6.63 · $6,384
Loading xslF345X05/form4.xml…